Search
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved: patients, their carers, cancer treaters, and treatment manufactures.
-
Is facing your mortality sparking the ‘Great Resignation’? Why we don’t want to work anymore
A combination of burnout, disengagement, ‘unpaid labor’ and more is pushing workers to make drastic career moves.
-
Healthcare Cybersecurity Insights + Tips
Discover research examining the attitudes, concerns, and impacts on medical device security, as well as cybersecurity across large and midsize healthcare delivery organizations.
-
Are EV Owners Charged Up about Quality?
Listen in to hear research exploring automotive quality perceptions in electric vehicles.
-
Black, Hispanic, and Asian Americans are much less likely to report good water and air quality in their communities
Axios-Ipsos Hard Truths Environmental Racism study finds minority Americans also experience more problems with weather-related infrastructure failures.
-
Pharma utilization and cost management for self-funded employers
Listen in to hear healthcare research insights to drive pricing and market access strategies for the pharma sector.
-
Remember back-to-school shopping? It’s back.
Our latest Thought Starter explores back-to-school spending trends and families’ expectations for the academic year ahead.
-
Shifting Autonomous From ‘Scary’ to ‘Safe’ for Drivers
We share research and tips to help auto manufacturers and marketers promote the safety of autonomous and ADAS features.
-
Electric Vehicles: Insights to Jump Start Demand
Listen in to hear new research exploring interest for EVs, their advantages and drawbacks plus key insights on how these have changed over the last several years.
-
Three quarters of Americans with health insurance coverage believe too many hurdles exist between patients and doctor-prescribed medicines
New Ipsos poll conducted with Novartis finds that 92% of patients believe that doctors should be making therapy decisions, not insurers